Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,94 USD | -2,72% | +0,77% | +12,25% |
25/04 | Transcript : Aldeyra Therapeutics, Inc. - Special Call | |
03/04 | ALDEYRA THERAPEUTICS, INC. : Oppenheimer herziet advies naar Kopen | ZM |
Omzet 2024 * | 24,88 mln. 23,28 mln. | Omzet 2025 * | 32,7 mln. 30,61 mln. | Marktkapitalisatie | 234 mln. 219 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -6 mln. -5,62 mln. | Nettowinst (verlies) 2025 * | -24 mln. -22,46 mln. | EV/omzet 2024 * | 9,41 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 7,16 x |
K/w-verhouding 2024 * |
-29,3
x | K/w-verhouding 2025 * |
-9,95
x | Werknemers | 10 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 82,39% |
Recentste transcriptie over Aldeyra Therapeutics, Inc.
1 dag | -2,72% | ||
1 week | +0,77% | ||
1 maand | +20,49% | ||
3 maanden | +25,88% | ||
6 maanden | +130,41% | ||
Lopend jaar | +12,25% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Todd Brady
CEO | Chief Executive Officer | 52 | 01-09-05 |
Bruce Greenberg
DFI | Director of Finance/CFO | 56 | 01-12-19 |
Caitlin Pazzano
PRN | Corporate Officer/Principal | - | 01-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gary Phillips
BRD | Director/Board Member | 58 | 01-05-09 |
Martin Joyce
BRD | Director/Board Member | 70 | 01-10-13 |
Ben Bronstein
BRD | Director/Board Member | 74 | 01-06-10 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +1,51% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 3,94 | -2,72% | 273 896 |
29-04-24 | 4,05 | +3,05% | 393 326 |
26-04-24 | 3,93 | -0,25% | 267 876 |
25-04-24 | 3,94 | -.--% | 462 606 |
24-04-24 | 3,94 | +0,77% | 570 606 |
uitgestelde koers Nasdaq, 30 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,25% | 234 mln. | |
-3,46% | 102 mld. | |
+1,41% | 96,09 mld. | |
+2,13% | 22,28 mld. | |
-15,84% | 21,4 mld. | |
-9,21% | 18,14 mld. | |
-39,98% | 17,02 mld. | |
-14,65% | 16,09 mld. | |
+4,39% | 13,83 mld. | |
+31,35% | 11,97 mld. |